Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation

Cell

Volumn 137, Issue 1, 2009, Pages 60-72

  Jeong, Hyunkyung ^a   Then, Florian ^a   Melia Jr , Thomas J ^b   Mazzulli, Joseph R ^a   Cui, Libin ^a   Savas, Jeffrey N ^c   Voisine, Cindy ^a   Paganetti, Paolo ^d   Tanese, Naoko ^c   Hart, Anne C ^a   Yamamoto, Ai ^e   Krainc, Dimitri ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

MOLNEURO

Indexed keywords

HUNTINGTIN; LYSINE; MUTANT PROTEIN;

ACETYLATION; ANIMAL CELL; ARTICLE; BRAIN CELL; CAENORHABDITIS ELEGANS; CELL MIGRATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; NERVE CELL CULTURE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; STRIATE CORTEX;

CAENORHABDITIS ELEGANS;

EID: 63049132756     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.03.018     Document Type: Article

References (48)

1. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
2. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384 (1996) 641-643
3. Bates E.A., Victor M., Jones A.K., Shi Y., and Hart A.C. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J. Neurosci. 26 (2006) 2830-2838
4. Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., and Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171 (2005) 603-614
5. Cuervo A.M. Autophagy: many paths to the same end. Mol. Cell. Biochem. 263 (2004) 55-72
6. Cui L., Jeong H., Borovecki F., Parkhurst C., Tanese N., and Krainc D. Repression of PGC-1alpha gene transcription by mutant huntingtin leads to mitochondrial dysfunction in Huntington's disease. Cell 126 (2006) 59-69
7. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
8. Dunah A.W., Jeong H., Griffin A., Kim M.J., Standaert D.G., Hersch S.M., Mouradian M.M., Young A.B., Tanese N., and Krainc D. Sp1 and TAF130 transcriptional activity disrupted in early Huntington's Disease. Science 296 (2002) 2238
9. Faber P.W., Alter J.R., MacDonald M.E., and Hart A.C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl. Acad. Sci. USA 96 (1999) 179-184
10. Graham R.K., Deng Y., Slow E.J., Haigh B., Bissada N., Lu G., Pearson J., Shehadeh J., Bertram L., Murphy Z., et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125 (2006) 1179-1191
11. Graham R.K., Slow E.J., Deng Y., Bissada N., Lu G., Pearson J., Shehadeh J., Leavitt B.R., Raymond L.A., and Hayden M.R. Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol. Dis. 21 (2006) 444-455
12. Hackam A.S., Singaraja R., Wellington C.L., Metzler M., McCutcheon K., Zhang T., Kalchman M., and Hayden M.R. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141 (1998) 1097-1105
13. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
14. Hart A.C., Kass J., Shapiro J.E., and Kaplan J.M. Distinct signaling pathways mediate touch and osmosensory responses in a polymodal sensory neuron. J. Neurosci. 19 (1999) 1952-1958
15. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., and Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19 (2000) 5720-5728
16. Kegel K.B., Kim M., Sapp E., McIntyre C., Castano J.G., Aronin N., and DiFiglia M. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 20 (2000) 7268-7278
17. Kegel K.B., Meloni A.R., Yi Y., Kim Y.J., Doyle E., Cuiffo B.G., Sapp E., Wang Y., Qin Z.H., Chen J.D., et al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal Binding Protein, and represses transcription. J. Biol. Chem. 277 (2002) 7466-7476
18. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8 (2007) 931-937
19. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
20. Komatsu M., Waguri S., Koike M., Sou Y., Ueno T., Hara T., Mizushima N., Iwata J., Ezaki J., Murata S., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131 (2007) 1149-1163
21. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation?. EMBO J. 19 (2000) 1176-1179
22. Lawrence B.P., and Brown W.J. Inhibition of protein synthesis separates autophagic sequestration from the delivery of lysosomal enzymes. J. Cell Sci. 105 (1993) 473-480
23. Levine B., and Kroemer G. Autophagy in the pathogenesis of disease. Cell 132 (2008) 27-42
24. Lunkes A., and Mandel J.L. A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet. 7 (1998) 1355-1361
25. Marzella L., Ahlberg J., and Glaumann H. Isolation of autophagic vacuoles from rat liver: morphological and biochemical characterization. J. Cell Biol. 93 (1982) 144-154
26. Mazzulli J.R., Mishizen A.J., Giasson B.I., Lynch D.R., Thomas S.A., Nakashima A., Nagatsu T., Ota A., and Ischiropoulos H. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J. Neurosci. 26 (2006) 10068-10078
27. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., and Chesselet M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 465 (2003) 11-26
28. Mizushima N. Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 36 (2004) 2491-2502
29. Nagaoka U., Kim K., Jana N.R., Doi H., Maruyama M., Mitsui K., Oyama F., and Nukina N. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J. Neurochem. 91 (2004) 57-68
30. Nixon R.A. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging 26 (2005) 373-382
31. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
32. Perutz M.F. Glutamine repeats and nueodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24 (1999) 58-63
33. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., Scaravilli F., Easton D.F., Duden R., O'Kane C.J., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36 (2004) 585-595
34. Reggiori F., and Klionsky D.J. Autophagy in the eukaryotic cell. Eukaryot. Cell 1 (2002) 11-21
35. Régulier E., Trottier Y., Perrin V., Aebischer P., and Déglon N. Early and reversible neuropathology induced by tetracycline-regulated overexpression of mutant huntingtin in rat striatum. Hum. Mol. Genet. 12 (2003) 2827-2836
36. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 Suppl. (2004) S10-S17
37. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., and DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42 (1997) 604-612
38. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G.P., Davies S.W., Lehrach H., and Wanker E.E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90 (1997) 549-558
39. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greenwald M., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413 (2001) 739-743
40. Stromhaug P.E., Berg T.O., Fengsrud M., and Seglen P.O. Purification and characterization of autophagosomes from rat hepatocytes. Biochem. J. 335 (1998) 217-224
41. Tanida I., Minematsu-Ikeguchi N., Ueno T., and Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1 (2005) 84-91
42. Voisine C., and Hart A.C. Caenorhabditis elegans as a model system for triplet repeat diseases. Methods Mol. Biol. 277 (2004) 141-160
43. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 (1998) 369-384
44. Weiss A., Roscic A., and Paganetti P. Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction. Mol. Neurodegener. 9 (2009) 11-23
45. Wheeler V.C., Auerbach W., White J.K., Srinidhi J., Auerbach A., Ryan A., Duyao M.P., Vrbanac V., Weaver M., Gusella J.F., et al. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 8 (1999) 115-122
46. Yamamoto A., Lucas J.J., and Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101 (2000) 57-66
47. Yamamoto A., Cremona M.L., and Rothman J.E. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J. Cell Biol. 172 (2006) 719-731
48. Zhai W., Jeong H., Cui L., Krainc D., and Tjian R. In vitro analysis of huntingtin mediated transcriptional repression reveals novel target and mechanism. Cell 123 (2005) 1241-1253